Xenon Pharmaceuticals Inc

(NASDAQ:XENE)

Latest On Xenon Pharmaceuticals Inc (XENE):

Date/Time Type Description Signal Details
2023-05-23 19:33 ESTNewsXenon Pharmaceuticals: Navigating The Neural Network Of Epilepsy And DepressionN/A
2023-05-13 22:20 ESTNewsXenon Pharmaceuticals Inc. (XENE) Q1 2023 Earnings Call TranscriptN/A
2023-05-09 20:01 ESTNewsXenon Pharma GAAP EPS of -$0.63 beats by $0.01N/A
2023-05-09 05:53 ESTNewsXenon Pharma Q1 2023 Earnings PreviewN/A
2023-03-15 18:51 ESTNewsXenon May Have A Surprise In Store For Major Depressive DisorderN/A
2023-03-02 08:45 ESTNewsXenon Pharmaceuticals Inc. (XENE) Q4 2022 Earnings Call TranscriptN/A
2023-03-01 18:23 ESTNewsXenon Pharma GAAP EPS of -$0.57 beats by $0.02N/A
2023-03-01 03:05 ESTNewsXenon Pharma Q4 2022 Earnings PreviewN/A
2023-02-08 14:29 ESTNewsXenon Pharmaceuticals: De-Risked Late-Stage Neurology Biotech, BuyN/A
2022-12-23 16:03 ESTNewsXenon Pharmaceuticals: Momentum Still Accelerating, Rate Buy (Technical Analysis)N/A
2022-11-28 20:23 ESTNewsXenon initiated Overweight at Wells Fargo on prospects in depressionN/A
2022-11-08 21:25 ESTNewsXenon Pharma GAAP EPS of -$0.57 misses by $0.05, revenue of $0.13M misses by $2.89MN/A
2022-11-08 21:24 ESTNewsXenon Pharmaceuticals Inc. (XENE) Q3 2022 Earnings Call TranscriptN/A
2022-10-19 16:36 ESTNewsXenon started at outperform at Raymond James on experimental epilepsy drugN/A
2022-09-06 17:12 ESTNewsPutting Xenon Pharmaceuticals Back In The SpotlightN/A
2022-08-29 20:33 ESTNewsXenon initiated with Buy at BofA citing potential of anti-seizure drugN/A
2022-08-11 01:42 ESTNewsXenon Pharmaceuticals Inc. (XENE) CEO Ian Mortimer on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-10 07:40 ESTNewsXenon Pharma GAAP EPS of -$0.55 misses by $0.06, revenue of $0.54M misses by $2.71MN/A
2022-08-09 11:57 ESTNewsXenon Pharma Q2 2022 Earnings PreviewN/A
2022-07-22 07:20 ESTNewsXenon added to JP Morgan’s analyst focus list citing lead assetN/A
2022-06-23 22:26 ESTNewsXenon Pharmaceuticals slides on pricing $250M equity offeringN/A
2022-06-23 22:26 ESTNewsHot Stocks: OXY rises as Buffett adds shares, SNOW pops on upgrade, KBH also gains and XENE declinesN/A
2022-06-23 03:58 ESTNewsXenon slips 11% on public offering of common stockN/A
2022-05-11 12:48 ESTNewsXenon Pharmaceuticals Inc. (XENE) CEO Ian Mortimer on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-10 17:11 ESTNewsXenon Pharma GAAP EPS of -$0.35 beats by $0.07, revenue of $8.77M beats by $1.03MN/A
2022-05-09 19:04 ESTNewsXenon Pharmaceuticals Q1 Earnings PreviewN/A
2022-03-02 08:46 ESTNewsXenon Pharma GAAP EPS of -$1.77 misses by $1.41, revenue of $18.43M beats by $12.13MN/A
2022-03-02 08:46 ESTNewsXenon Pharmaceuticals Inc. (XENE) CEO Ian Mortimer on Q4 2021 Results - Earnings Call TranscriptN/A
2022-01-19 20:02 ESTNewsXenon draws buyout speculation after Zogenix dealN/A
2022-01-12 13:22 ESTNewsXenon passes regulatory mark to receive $15M from Neurocrine BiosciencesN/A
2021-12-14 04:59 ESTNewsSizing Up Xenon PharmaceuticalsN/A
2021-12-11 00:58 ESTNewsXenon Pharmaceuticals (XENE) Presents At AES 2021 SymposiumN/A
2021-12-08 15:45 ESTNewsXenon Pharmaceuticals jumps 5% on insider buying worth $100KN/A
2021-12-07 00:52 ESTNewsXenon Pharmaceuticals (XENE) Investor Presentation - SlideshowN/A
2021-12-03 23:16 ESTNewsXenon Pharma presents additional positive data from Phase 2b X-TOLE trial at AES 2021N/A
2021-11-11 15:47 ESTNewsXenon Pharmaceuticals' (XENE) CEO Ian Mortimer on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-10 18:37 ESTNewsXenon Pharma EPS beats by $0.01, misses on revenueN/A
2021-11-09 19:56 ESTNewsXenon Pharma Q3 2021 Earnings PreviewN/A
2021-10-06 21:06 ESTNewsXenon Pharma secures $300M capital raise via equity offeringN/A
2021-10-05 18:52 ESTNewsXenon Pharmaceuticals rises ~4% amid launch of $250M stock offeringN/A
2021-10-04 16:06 ESTNewsXenon Pharma stock jumps 80% on positive XEN1101 data in mid-stage focal epilepsy studyN/A
2021-09-08 18:36 ESTNewsXenon Pharmaceuticals gets $10M milestone payment from Neurocrine collaborationN/A
2021-08-23 17:59 ESTNewsNew medical chief at Xenon PharmaN/A
2021-08-12 06:35 ESTNewsXenon Pharma EPS misses by $0.03, misses on revenueN/A
2021-08-12 06:34 ESTNewsXenon Pharmaceuticals Inc. (XENE) CEO Ian Mortimer on Q2 2021 Results - Earnings Call TranscriptN/A
2021-07-22 09:06 ESTNewsXenon completes patient randomization in mid-stage XEN1101 epilepsy trialN/A
2021-03-10 02:08 ESTNewsXenon Pharmaceuticals readies stock offeringN/A
2021-03-10 02:08 ESTNewsXenon Pharma secures $100M via equity raiseN/A
2021-03-09 06:58 ESTNewsXenon strikes research deal for major depressive disorder treatment XEN1101N/A
2021-03-04 12:48 ESTAnalyst RatingThe Analyst Target Price has increased from $25 to $25.29.Buy

About Xenon Pharmaceuticals Inc (XENE):

Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel modulator that is Phase III clinical trials for the treatment of KCNQ2 epilepsy encephalopathy; and XEN1101, A Kv7 potassium channel modulator, which is in Phase II clinical trial for the treatment of epilepsy and other neurological disorders. The company's product candidates also comprise NBI-921352, a selective Nav1.6 sodium channel inhibitor that is in Phase II clinical trials for the treatment of epilepsy; and XEN007, A central nervous system-acting calcium channel modulator, which is in Phase II clinical trials. The company has a license and collaboration agreement with the Neurocrine Biosciences, Inc. to develop treatments for epilepsy; and with Flexion Therapeutics, Inc. to develop FX301 (XEN402, a Nav1.7 inhibitor) for the treatment of post-operative pain. The company was incorporated in 1996 and is headquartered in Burnaby, Canada.

XENE Quotes by TradingView

See Advanced Chart

General

  • Name Xenon Pharmaceuticals Inc
  • Symbol XENE
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 123
  • Fiscal Year EndDecember
  • IPO Date2014-11-05
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.xenon-pharma.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 20.81
  • Price/Book (Most Recent Quarter) 4.24
  • Enterprise Value Revenue 16.42
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Next Quarter EPS Estimate -$0.45
  • Profit Margin -90%
  • Operating Margin -97%
  • Return on Assets -12%
  • Return on Equity -22%
  • Revenue 32.17 million
  • Earnings Per Share -$1.72
  • Revenue Per Share $0.93
  • Gross Profit -18357000
  • Quarterly Earnings Growth 54.7%
View More

Highlights

  • Market Capitalization 658.17 million
  • EBITDA -44423000
  • PE Ratio -18.63
  • PEG Ratio -0.06
  • Analyst Target Price $25.29
  • Book Value Per Share $4.67
View More

Share Statistics

  • Shares Outstanding 35.81 million
  • Shares Float 23.33 million
  • % Held by Insiders 658%
  • % Held by Institutions 81.3%
  • Shares Short 943938
  • Shares Short Prior Month 977125
  • Short Ratio 5.34
  • Short % of Float 3%
  • Short % of Shares Outstanding 3%
View More

Technicals

  • Beta 1.42
  • 52 Week High $21.94
  • 52 Week Low $8.95
  • 50 Day Moving Average 17.43
  • 200 Day Moving Average 13.52
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Xenon Pharmaceuticals Inc (XENE) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Xenon Pharmaceuticals Inc (XENE) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-01$5.15 million-$0.34-$0.4015%
2020-09-302020-11-05$N/A-$0.25-$0.17-47.06%
2020-06-302020-08-06$N/A$-0.00-$0.2097.52%
2020-03-312020-05-21$7.08 million-$0.22-$0.3129.6%
2019-12-312020-03-09$3.33 million-$0.41$0.12-441.67%
2019-09-302019-11-05$3.5 million-$0.33-$0.4628.26%
2019-06-302019-08-06$N/A-$0.37-$0.4518.38%
2019-03-312019-05-07$N/A-$0.42-$0.37-13.51%
2018-12-312019-03-06$N/A-$0.29-$0.3619.44%
2018-09-302018-11-06$N/A-$0.63-$0.40-57.5%
2018-06-302018-08-07$N/A-$0.45-$0.498.16%
2018-03-312018-05-08$N/A-$0.46-$0.484.96%
2017-12-312018-03-07$16000-$0.45-$0.44-2.27%
2017-09-302017-11-07$264000-$0.43-$0.39-10.26%
2017-06-302017-08-03$15000-$0.41-$0.39-6.03%
2017-03-312017-05-09$16000-$0.42-$0.38-9.57%
2016-12-312017-03-08$376000-$0.32-$0.4223.21%
2016-09-302016-11-03$413000-$0.51-$0.44-15.25%
2016-06-302016-08-03$413000-$0.42-$0.5016%
2016-03-312016-05-10$601000-$0.23-$0.21-9.52%
2015-12-312016-03-08$3.23 million-$0.27-$0.26-3.85%
2015-09-302015-11-10$4.29 million-$0.27-$0.01-2600%
2015-06-302015-08-10$4.05 million$0.08-$0.15153.33%
2015-03-312015-05-12$4.01 million-$0.30$0.14-314.29%
2014-12-312015-03-12$4.88 million$2.54-$0.0125500%
2014-09-302014-12-15$13.19 million$1.69

Xenon Pharmaceuticals Inc (XENE) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Xenon Pharmaceuticals Inc (XENE) Chart:

Xenon Pharmaceuticals Inc (XENE) News:

Below you will find a list of latest news for Xenon Pharmaceuticals Inc (XENE) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Xenon Pharmaceuticals Inc (XENE) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-07-1722.50CALL0 00TRUE00
2026-07-17250CALL0 0290.72TRUE00
2026-07-1727.50CALL0 00TRUE00
2026-07-17300CALL0 00TRUE00
2026-07-1732.50CALL0 00TRUE00
2026-07-17350CALL0 30TRUE00
2026-07-1737.50CALL0 20TRUE00
2026-07-17400CALL0 00TRUE00
2026-07-1742.50CALL0 0129.55TRUE00
2026-07-17450CALL0 100TRUE00
2026-07-1747.50CALL0 600TRUE00
2026-07-17500CALL0 10TRUE00
2026-07-1752.50CALL0 112121.15TRUE00
2026-07-17550CALL0 2500TRUE00
2026-07-1757.50CALL0 1786.24TRUE00
2026-07-17609.2CALL6 9978.35TRUE-2.8-0.23
2026-07-1762.58.22CALL0 2779.41TRUE00
2026-07-17655.5CALL10 31099.73TRUE-1-0.15
2026-07-1767.55.1CALL0 4895.95TRUE00
2026-07-17703.4CALL13 94390.65FALSE-0.78-0.19
2026-07-1772.50CALL0 0107.71FALSE00
2026-07-17751.78CALL25 8996124.49FALSE-1.42-0.44
2026-07-1777.50CALL0 0119.11FALSE00
2026-07-17801.8CALL0 1028125.58FALSE00
2026-07-17851.16CALL0 200156.46FALSE00
2026-07-17901CALL0 391153.33FALSE00
2026-07-17950CALL0 0209.24FALSE00
2026-07-171000CALL0 0228.51FALSE00
2026-07-171050CALL0 0245.8FALSE00
2026-07-1722.50PUT0 4617.92FALSE00
2026-07-17250PUT0 0568.18FALSE00
2026-07-1727.50PUT0 0520.36FALSE00
2026-07-17300PUT0 0477.01FALSE00
2026-07-1732.50PUT0 0437.31FALSE00
2026-07-17350PUT0 142400.62FALSE00
2026-07-1737.50PUT0 0366.47FALSE00
2026-07-17400PUT0 1334.46FALSE00
2026-07-1742.50PUT0 2306.25FALSE00
2026-07-17450PUT0 23277.47FALSE00
2026-07-1747.50PUT0 12250.01FALSE00
2026-07-17500PUT0 152225.22FALSE00
2026-07-1752.50PUT0 14199.65FALSE00
2026-07-17550PUT0 7176.13FALSE00
2026-07-1757.50PUT0 17152.87FALSE00
2026-07-17600.69PUT0 80131.79FALSE00
2026-07-1762.50PUT0 3697.16FALSE00
2026-07-17652PUT40 176.44FALSE11
2026-07-1767.52PUT0 22586.7FALSE00
2026-07-17704.19PUT0 36106.52TRUE00
2026-07-1772.50PUT0 0114.62TRUE00
2026-07-17750PUT0 2120.86TRUE00
2026-07-1777.50PUT0 0125.65TRUE00
2026-07-17800PUT0 5129.96TRUE00
2026-07-178517PUT4 4139.21TRUE0.50.03
2026-07-179022PUT4 4145.76TRUE10.05
2026-07-17950PUT0 0159.1TRUE00
2026-07-171000PUT0 0168.33TRUE00
2026-07-171050PUT0 0164.74TRUE00
2026-08-21300CALL0 083.26TRUE00
2026-08-2132.50CALL0 00TRUE00
2026-08-213534.43CALL3 3120.3TRUE34.430
2026-08-2137.50CALL0 283.92TRUE00
2026-08-21400CALL0 061.58TRUE00
2026-08-2142.50CALL0 071.85TRUE00
2026-08-214524.63CALL3 067.9TRUE24.630
2026-08-2147.50CALL0 263.18TRUE00
2026-08-21500CALL0 062.65TRUE00
2026-08-2152.50CALL0 059.81TRUE00
2026-08-21550CALL0 056.95TRUE00
2026-08-2157.50CALL0 058.61TRUE00
2026-08-216013.65CALL0 756.52TRUE00
2026-08-2162.50CALL0 062.59TRUE00
2026-08-216510.35CALL0 4964.07TRUE00
2026-08-2167.50CALL0 065.63TRUE00
2026-08-21706.6CALL0 23658.74FALSE00
2026-08-2172.50CALL0 065.34FALSE00
2026-08-21755.01CALL0 7765.15FALSE00
2026-08-2177.50CALL0 066.89FALSE00
2026-08-21802.59CALL2 173.8FALSE2.590
2026-08-21852CALL0 368.21FALSE00
2026-08-21900CALL0 274.97FALSE00
2026-08-21950CALL0 082.67FALSE00
2026-08-211000.85CALL1 089.33FALSE0.850
2026-08-211050.65CALL1 096.11FALSE0.650
2026-08-21300PUT0 0184.19FALSE00
2026-08-2132.50PUT0 0168.92FALSE00
2026-08-21350PUT0 0155.75FALSE00
2026-08-2137.50PUT0 0142.56FALSE00
2026-08-21400PUT0 0130.2FALSE00
2026-08-2142.50PUT0 0119.29FALSE00
2026-08-21450PUT0 0108.87FALSE00
2026-08-2147.50PUT0 098.85FALSE00
2026-08-21500PUT0 089.18FALSE00
2026-08-2152.50PUT0 080.3FALSE00
2026-08-21550PUT0 273.91FALSE00
2026-08-2157.50PUT0 068.33FALSE00
2026-08-21600PUT0 063.14FALSE00
2026-08-2162.50PUT0 364.79FALSE00
2026-08-21653.7PUT0 367.91FALSE00
2026-08-2167.50PUT0 10670.45FALSE00
2026-08-21706.4PUT0 566.23TRUE00
2026-08-2172.50PUT0 066.35TRUE00
2026-08-21750PUT0 165.95TRUE00
2026-08-2177.50PUT0 066.28TRUE00
2026-08-21800PUT0 073.83TRUE00
2026-08-21850PUT0 067.4TRUE00
2026-08-21900PUT0 069.61TRUE00
2026-08-21950PUT0 071.36TRUE00
2026-08-211000PUT0 075.43TRUE00
2026-08-211050PUT0 079.56TRUE00
2026-10-1622.50CALL0 00TRUE00
2026-10-16250CALL0 080.31TRUE00
2026-10-1627.50CALL0 078.19TRUE00
2026-10-16300CALL0 074.75TRUE00
2026-10-1632.50CALL0 070.76TRUE00
2026-10-16350CALL0 066.54TRUE00
2026-10-1637.50CALL0 067.58TRUE00
2026-10-16400CALL0 062.48TRUE00
2026-10-1642.50CALL0 059.26TRUE00
2026-10-16450CALL0 058.32TRUE00
2026-10-1647.50CALL0 059.17TRUE00
2026-10-16500CALL0 058.27TRUE00
2026-10-1652.50CALL0 058.26TRUE00
2026-10-16550CALL0 358.08TRUE00
2026-10-1657.50CALL0 057.74TRUE00
2026-10-166014CALL0 1556.35TRUE00
2026-10-1662.50CALL0 156.96TRUE00
2026-10-16650CALL0 1056.86TRUE00
2026-10-1667.50CALL0 1856.93TRUE00
2026-10-16700CALL0 157.18FALSE00
2026-10-1672.50CALL0 056.93FALSE00
2026-10-16757.7CALL0 1456.61FALSE00
2026-10-1677.50CALL0 056.98FALSE00
2026-10-16804.43CALL1 5856.84FALSE-0.07-0.02
2026-10-16854.14CALL0 154.66FALSE00
2026-10-16902.2CALL132 890357.41FALSE-0.3-0.12
2026-10-16950CALL0 060.64FALSE00
2026-10-161000CALL0 061.09FALSE00
2026-10-161050CALL0 063.87FALSE00
2026-10-1622.50PUT0 6156.55FALSE00
2026-10-16250PUT0 4143.2FALSE00
2026-10-1627.50PUT0 0131.24FALSE00
2026-10-16300PUT0 4121.09FALSE00
2026-10-1632.50PUT0 1111.12FALSE00
2026-10-16350PUT0 0102.5FALSE00
2026-10-1637.50PUT0 193.89FALSE00
2026-10-16401.33PUT0 186.84FALSE00
2026-10-1642.50PUT0 779.64FALSE00
2026-10-16450PUT0 973.63FALSE00
2026-10-1647.50PUT0 7868.14FALSE00
2026-10-16501.63PUT0 1164.78FALSE00
2026-10-1652.50PUT0 1360.4FALSE00
2026-10-16550PUT0 558.27FALSE00
2026-10-1657.50PUT0 060FALSE00
2026-10-16600PUT0 059.01FALSE00
2026-10-1662.54.25PUT0 156.94FALSE00
2026-10-16650PUT0 458.1FALSE00
2026-10-1667.50PUT0 059.32FALSE00
2026-10-16708.7PUT40 1056.77TRUE0.960.12
2026-10-1672.510PUT12 057.31TRUE100
2026-10-16750PUT0 357.06TRUE00
2026-10-1677.50PUT0 056.76TRUE00
2026-10-16800PUT0 056.84TRUE00
2026-10-16850PUT0 056.53TRUE00
2026-10-16900PUT0 056.19TRUE00
2026-10-16950PUT0 056.47TRUE00
2026-10-161000PUT0 057.85TRUE00
2026-10-161050PUT0 060.05TRUE00
2026-12-18200CALL0 092.23TRUE00
2026-12-1822.50CALL0 064.52TRUE00
2026-12-18250CALL0 061.45TRUE00
2026-12-1827.50CALL0 057.97TRUE00
2026-12-18300CALL0 066.41TRUE00
2026-12-1832.50CALL0 058.52TRUE00
2026-12-18350CALL0 156.33TRUE00
2026-12-1837.50CALL0 056.91TRUE00
2026-12-18400CALL0 054.68TRUE00
2026-12-1842.50CALL0 153.99TRUE00
2026-12-18450CALL0 1653.17TRUE00
2026-12-1847.50CALL0 053.43TRUE00
2026-12-18500CALL0 1752.61TRUE00
2026-12-1852.50CALL0 2751.99TRUE00
2026-12-18550CALL0 2852.26TRUE00
2026-12-1857.50CALL0 252.74TRUE00
2026-12-18600CALL0 252.39TRUE00
2026-12-1862.50CALL0 152TRUE00
2026-12-18650CALL0 3551.88TRUE00
2026-12-1867.50CALL0 051.71TRUE00
2026-12-18700CALL0 1351.24FALSE00
2026-12-1872.50CALL0 051.33FALSE00
2026-12-18750CALL0 050.34FALSE00
2026-12-1877.50CALL0 049.66FALSE00
2026-12-18800CALL0 6749.33FALSE00
2026-12-18854.7CALL0 548.56FALSE00
2026-12-18900CALL0 246.17FALSE00
2026-12-18952.75CALL0 546.05FALSE00
2026-12-181002CALL1 047.47FALSE20
2026-12-181051.55CALL1 049.7FALSE1.550
2026-12-18200PUT0 4106.44FALSE00
2026-12-1822.50PUT0 0121.77FALSE00
2026-12-18250PUT0 0111.42FALSE00
2026-12-1827.50PUT0 0102.15FALSE00
2026-12-18300PUT0 590.88FALSE00
2026-12-1832.50PUT0 186.57FALSE00
2026-12-18350PUT0 1579.91FALSE00
2026-12-1837.50PUT0 174.1FALSE00
2026-12-18400PUT0 1268.59FALSE00
2026-12-1842.50.9PUT1 064.04FALSE0.90
2026-12-18450PUT0 260.54FALSE00
2026-12-1847.51.6PUT1 256.63FALSE1.60
2026-12-18500PUT0 456.22FALSE00
2026-12-1852.52.2PUT1 053.7FALSE2.20
2026-12-18550PUT0 153.03FALSE00
2026-12-1857.50PUT0 051.14FALSE00
2026-12-18604.25PUT0 552.61FALSE00
2026-12-1862.50PUT0 051.15FALSE00
2026-12-18656.2PUT0 554.18FALSE00
2026-12-1867.50PUT0 051.22FALSE00
2026-12-18700PUT0 051.16TRUE00
2026-12-1872.50PUT0 050.8TRUE00
2026-12-18750PUT0 050.45TRUE00
2026-12-1877.50PUT0 049.57TRUE00
2026-12-18800PUT0 049.28TRUE00
2026-12-18850PUT0 048.68TRUE00
2026-12-18900PUT0 048.42TRUE00
2026-12-18950PUT0 048.15TRUE00
2026-12-181000PUT0 047.82TRUE00
2026-12-181050PUT0 048.53TRUE00
2027-01-1522.50CALL0 183.25TRUE00
2027-01-15250CALL0 578.63TRUE00
2027-01-1527.50CALL0 076TRUE00
2027-01-15300CALL0 072.87TRUE00
2027-01-1532.50CALL0 269.48TRUE00
2027-01-15350CALL0 2467.02TRUE00
2027-01-1537.50CALL0 165.09TRUE00
2027-01-15400CALL0 260.36TRUE00
2027-01-1542.50CALL0 559.3TRUE00
2027-01-15450CALL0 158.75TRUE00
2027-01-1547.50CALL0 3956.97TRUE00
2027-01-15500CALL0 356.1TRUE00
2027-01-1552.521.5CALL0 1254.66TRUE00
2027-01-155519.7CALL0 1454.19TRUE00
2027-01-1557.50CALL0 053.45TRUE00
2027-01-15600CALL0 353.1TRUE00
2027-01-1562.50CALL0 1053.05TRUE00
2027-01-15650CALL0 052.72TRUE00
2027-01-1567.512.65CALL0 452.69TRUE00
2027-01-157011.24CALL0 3852.42FALSE00
2027-01-1572.50CALL0 051.19FALSE00
2027-01-15750CALL0 1551.05FALSE00
2027-01-1577.50CALL0 050.49FALSE00
2027-01-15807CALL0 850.81FALSE00
2027-01-15850CALL0 248.57FALSE00
2027-01-15900CALL0 3646.57FALSE00
2027-01-15953.6CALL0 18551.01FALSE00
2027-01-151000CALL0 046.46FALSE00
2027-01-151051.8CALL2 048.17FALSE1.80
2027-01-1522.50PUT0 0114.55FALSE00
2027-01-15250PUT0 0105.43FALSE00
2027-01-1527.50PUT0 097.23FALSE00
2027-01-15300PUT0 090.25FALSE00
2027-01-1532.50PUT0 283.36FALSE00
2027-01-15350PUT0 177.78FALSE00
2027-01-1537.50PUT0 172.11FALSE00
2027-01-15400PUT0 167.09FALSE00
2027-01-1542.50PUT0 062.89FALSE00
2027-01-15451.45PUT1 3359.58FALSE1.450
2027-01-1547.50PUT0 12057.89FALSE00
2027-01-15500PUT0 654.89FALSE00
2027-01-1552.50PUT0 27553.31FALSE00
2027-01-15550PUT0 153.08FALSE00
2027-01-1557.50PUT0 052.53FALSE00
2027-01-15600PUT0 152.61FALSE00
2027-01-1562.50PUT0 052.22FALSE00
2027-01-15650PUT0 1251.01FALSE00
2027-01-1567.50PUT0 150.93FALSE00
2027-01-15700PUT0 051.1TRUE00
2027-01-1572.50PUT0 051.53TRUE00
2027-01-15750PUT0 2151TRUE00
2027-01-1577.50PUT0 050.26TRUE00
2027-01-15800PUT0 050.13TRUE00
2027-01-15850PUT0 149.13TRUE00
2027-01-15900PUT0 048.78TRUE00
2027-01-15950PUT0 048.08TRUE00
2027-01-151000PUT0 048.9TRUE00
2027-01-151050PUT0 049.44TRUE00
2028-01-2127.50CALL0 058.6TRUE00
2028-01-21300CALL0 4057.94TRUE00
2028-01-2132.50CALL0 157.28TRUE00
2028-01-21350CALL0 055.8TRUE00
2028-01-2137.50CALL0 055.9TRUE00
2028-01-21400CALL0 555.52TRUE00
2028-01-2142.50CALL0 054.8TRUE00
2028-01-21450CALL0 053.82TRUE00
2028-01-2147.50CALL0 053.85TRUE00
2028-01-21500CALL0 153.55TRUE00
2028-01-2152.50CALL0 054.05TRUE00
2028-01-21550CALL0 1954.23TRUE00
2028-01-2157.526.5CALL0 254.34TRUE00
2028-01-216024.3CALL0 3153.87TRUE00
2028-01-2162.50CALL0 1752.54TRUE00
2028-01-21650CALL0 3852.78TRUE00
2028-01-2167.50CALL0 052.83TRUE00
2028-01-217021.7CALL0 2053.02FALSE00
2028-01-2172.50CALL0 051.81FALSE00
2028-01-217516.63CALL10 3652.64FALSE16.630
2028-01-2177.50CALL0 050.74FALSE00
2028-01-21800CALL0 850.84FALSE00
2028-01-21850CALL0 1350.68FALSE00
2028-01-219011.83CALL10 2050.07FALSE-0.92-0.07
2028-01-21950CALL0 049.05FALSE00
2028-01-211009CALL0 449.14FALSE00
2028-01-211050CALL0 048.13FALSE00
2028-01-2127.50PUT0 072.24FALSE00
2028-01-21300PUT0 066.63FALSE00
2028-01-2132.50PUT0 061.52FALSE00
2028-01-21350PUT0 056.83FALSE00
2028-01-2137.50PUT0 054.6FALSE00
2028-01-21400PUT0 053.61FALSE00
2028-01-2142.50PUT0 052.94FALSE00
2028-01-21450PUT0 052.25FALSE00
2028-01-2147.50PUT0 052.26FALSE00
2028-01-21500PUT0 052.6FALSE00
2028-01-2152.50PUT0 153.41FALSE00
2028-01-21550PUT0 12253.28FALSE00
2028-01-2157.50PUT0 052.72FALSE00
2028-01-21600PUT0 153.22FALSE00
2028-01-2162.50PUT0 052.61FALSE00
2028-01-21650PUT0 452.66FALSE00
2028-01-2167.50PUT0 052.69FALSE00
2028-01-21700PUT0 052.53TRUE00
2028-01-2172.50PUT0 051.59TRUE00
2028-01-21750PUT0 052.36TRUE00
2028-01-2177.50PUT0 052.05TRUE00
2028-01-21800PUT0 050.69TRUE00
2028-01-21850PUT0 050.3TRUE00
2028-01-21900PUT0 049.83TRUE00
2028-01-21950PUT0 049.76TRUE00
2028-01-211000PUT0 048.63TRUE00
2028-01-211050PUT0 048.2TRUE00

Latest XENE Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST5$27.26
Jun 13, 2022 7:59 PM EST89$27.26
Jun 13, 2022 7:59 PM EST5$27.24
Jun 13, 2022 7:59 PM EST3$27.24
Jun 13, 2022 7:59 PM EST26$27.24

Xenon Pharmaceuticals Inc (XENE) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-22SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000092189520001824/0000921895-20-001824-index.htm
2019-08-12UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1582313/000000000019012321/0000000000-19-012321-index.htm
2020-06-10UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1582313/000000000020005143/0000000000-20-005143-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000085874419000023/0000858744-19-000023-index.htm
2018-12-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000089924318030608/0000899243-18-030608-index.htm
2019-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000089924319007264/0000899243-19-007264-index.htm
2019-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000089924319008569/0000899243-19-008569-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000089924319014470/0000899243-19-014470-index.htm
2018-07-03SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000090266418002713/0000902664-18-002713-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000090266419000946/0000902664-19-000946-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000090266419001016/0000902664-19-001016-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000090266420000959/0000902664-20-000959-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000092189519000466/0000921895-19-000466-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000092189520000548/0000921895-20-000548-index.htm
2020-06-22SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000092189520001824/0000921895-20-001824-index.htm
2018-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000117184318004459/0001171843-18-004459-index.htm
2018-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000117184318004460/0001171843-18-004460-index.htm
2018-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000117184318004461/0001171843-18-004461-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000117184318004695/0001171843-18-004695-index.htm
2018-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000117184318004795/0001171843-18-004795-index.htm
2018-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000117184318004796/0001171843-18-004796-index.htm
2018-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000117184318008430/0001171843-18-008430-index.htm
2018-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000117184318008471/0001171843-18-008471-index.htm
2018-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000117184318008556/0001171843-18-008556-index.htm
2019-09-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119049538/0001209191-19-049538-index.htm
2019-09-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119049550/0001209191-19-049550-index.htm
2019-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119049864/0001209191-19-049864-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050127/0001209191-19-050127-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050129/0001209191-19-050129-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050131/0001209191-19-050131-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050133/0001209191-19-050133-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050136/0001209191-19-050136-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050143/0001209191-19-050143-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050146/0001209191-19-050146-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050148/0001209191-19-050148-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050164/0001209191-19-050164-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050166/0001209191-19-050166-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050169/0001209191-19-050169-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050172/0001209191-19-050172-index.htm
2019-09-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050318/0001209191-19-050318-index.htm
2019-09-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050588/0001209191-19-050588-index.htm
2019-11-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119057754/0001209191-19-057754-index.htm
2019-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119059515/0001209191-19-059515-index.htm
2019-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119060910/0001209191-19-060910-index.htm
2020-01-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120003271/0001209191-20-003271-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120003273/0001209191-20-003273-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120018941/0001209191-20-018941-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120018951/0001209191-20-018951-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120018958/0001209191-20-018958-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120018963/0001209191-20-018963-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120018969/0001209191-20-018969-index.htm
2020-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120032628/0001209191-20-032628-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120033578/0001209191-20-033578-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120033588/0001209191-20-033588-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120033593/0001209191-20-033593-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120033596/0001209191-20-033596-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120033605/0001209191-20-033605-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120033627/0001209191-20-033627-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120033639/0001209191-20-033639-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120033643/0001209191-20-033643-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120033653/0001209191-20-033653-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120033669/0001209191-20-033669-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120035608/0001209191-20-035608-index.htm
2020-08-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120046970/0001209191-20-046970-index.htm
2020-08-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120046974/0001209191-20-046974-index.htm
2020-08-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120048095/0001209191-20-048095-index.htm
2020-10-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120056222/0001209191-20-056222-index.htm
2020-10-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120056229/0001209191-20-056229-index.htm
2020-11-053Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120057205/0001209191-20-057205-index.htm
2020-11-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120057208/0001209191-20-057208-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000121390020003603/0001213900-20-003603-index.htm
2018-06-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000142284918000162/0001422849-18-000162-index.htm
2018-08-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000142284918000178/0001422849-18-000178-index.htm
2018-06-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018015497/0001564590-18-015497-index.htm
2018-07-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018016554/0001564590-18-016554-index.htm
2018-07-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1582313/000156459018016768/0001564590-18-016768-index.htm
2018-07-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018016771/0001564590-18-016771-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018020000/0001564590-18-020000-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018020005/0001564590-18-020005-index.htm
2018-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1582313/000156459018020018/0001564590-18-020018-index.htm
2018-08-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018022422/0001564590-18-022422-index.htm
2018-09-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018022703/0001564590-18-022703-index.htm
2018-09-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018022911/0001564590-18-022911-index.htm
2018-09-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018023027/0001564590-18-023027-index.htm
2018-09-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1582313/000156459018023031/0001564590-18-023031-index.htm
2018-09-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018023099/0001564590-18-023099-index.htm
2018-09-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1582313/000156459018023102/0001564590-18-023102-index.htm
2018-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018027409/0001564590-18-027409-index.htm
2018-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1582313/000156459018027475/0001564590-18-027475-index.htm
2019-03-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459019006512/0001564590-19-006512-index.htm
2019-03-0610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1582313/000156459019006514/0001564590-19-006514-index.htm
2019-03-06S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1582313/000156459019006522/0001564590-19-006522-index.htm
2019-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459019007593/0001564590-19-007593-index.htm
2019-03-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459019009156/0001564590-19-009156-index.htm
2019-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1582313/000156459019013752/0001564590-19-013752-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459019016573/0001564590-19-016573-index.htm
2019-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1582313/000156459019016580/0001564590-19-016580-index.htm
2019-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459019021713/0001564590-19-021713-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459019029412/0001564590-19-029412-index.htm
2019-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1582313/000156459019029418/0001564590-19-029418-index.htm
2019-08-06S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1582313/000156459019029440/0001564590-19-029440-index.htm
2019-08-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1582313/000156459019031813/0001564590-19-031813-index.htm
2019-09-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459019034466/0001564590-19-034466-index.htm
2019-09-13S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1582313/000156459019034720/0001564590-19-034720-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459019040445/0001564590-19-040445-index.htm
2019-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1582313/000156459019040449/0001564590-19-040449-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459019040458/0001564590-19-040458-index.htm
2019-11-05424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1582313/000156459019040484/0001564590-19-040484-index.htm
2019-12-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459019044971/0001564590-19-044971-index.htm
2019-12-11SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1582313/000156459019045741/0001564590-19-045741-index.htm
2020-01-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020000685/0001564590-20-000685-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020000901/0001564590-20-000901-index.htm
2020-01-22424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1582313/000156459020001642/0001564590-20-001642-index.htm
2020-01-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020001789/0001564590-20-001789-index.htm
2020-01-23424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1582313/000156459020001790/0001564590-20-001790-index.htm
2020-03-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020009357/0001564590-20-009357-index.htm
2020-03-0910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1582313/000156459020009385/0001564590-20-009385-index.htm
2020-03-09S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1582313/000156459020009391/0001564590-20-009391-index.htm
2020-03-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020010133/0001564590-20-010133-index.htm
2020-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020010811/0001564590-20-010811-index.htm
2020-04-28DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1582313/000156459020019198/0001564590-20-019198-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020021912/0001564590-20-021912-index.htm
2020-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020026545/0001564590-20-026545-index.htm
2020-05-2110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1582313/000156459020026574/0001564590-20-026574-index.htm
2020-05-2210-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1582313/000156459020026739/0001564590-20-026739-index.htm
2020-05-2610-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1582313/000156459020026807/0001564590-20-026807-index.htm
2020-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020028137/0001564590-20-028137-index.htm
2020-06-03S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1582313/000156459020028139/0001564590-20-028139-index.htm
2020-06-03S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1582313/000156459020028142/0001564590-20-028142-index.htm
2020-06-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1582313/000156459020028884/0001564590-20-028884-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020037751/0001564590-20-037751-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1582313/000156459020037862/0001564590-20-037862-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020037867/0001564590-20-037867-index.htm
2020-08-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1582313/000156459020037893/0001564590-20-037893-index.htm
2020-08-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020040375/0001564590-20-040375-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020051310/0001564590-20-051310-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1582313/000156459020051443/0001564590-20-051443-index.htm
2018-07-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000161577418006468/0001615774-18-006468-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000161577419002513/0001615774-19-002513-index.htm
2019-08-15EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1582313/999999999519001895/9999999995-19-001895-index.htm
2020-06-12EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1582313/999999999520001418/9999999995-20-001418-index.htm
2018-09-11CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1582313/999999999718007811/9999999997-18-007811-index.htm
2018-12-17CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1582313/999999999718009592/9999999997-18-009592-index.htm
2019-09-11CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1582313/999999999719006777/9999999997-19-006777-index.htm
2019-09-11CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1582313/999999999719006778/9999999997-19-006778-index.htm
2020-02-06SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1582313/999999999720000547/9999999997-20-000547-index.htm
2020-02-27SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1582313/999999999720001048/9999999997-20-001048-index.htm
2020-09-01CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1582313/999999999720004559/9999999997-20-004559-index.htm

Xenon Pharmaceuticals Inc (XENE) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Xenon Pharmaceuticals Inc (XENE). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 658%
Institutional Ownership: 8130%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-09-20FRANK A HOLLERDirectorSell5,206.009.3948,884.34118,955.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119050318/0001209191-19-050318-index.htm
2019-09-12SHERRINGTON ROBINEVP, Strategy & InnovationBuy6,172.003.0718,948.0412,064.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119049538/0001209191-19-049538-index.htm
2019-09-12FRANK A HOLLERDirectorBuy3,086.003.7011,418.20122,041.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119049550/0001209191-19-049550-index.htm
2020-05-29FRANK A HOLLERDirectorBuy3,086.003.5610,986.16122,041.00https://www.sec.gov/Archives/edgar/data/1582313/000120919120033588/0001209191-20-033588-index.htm
2019-09-19FRANK A HOLLERDirectorSell7,600.009.2770,452.00124,161.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119050318/0001209191-19-050318-index.htm
2019-09-12FRANK A HOLLERDirectorBuy3,086.003.079,474.02124,193.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119049550/0001209191-19-049550-index.htm
2019-09-18FRANK A HOLLERDirectorSell4,368.009.2840,535.04131,761.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119050136/0001209191-19-050136-index.htm
2019-09-17FRANK A HOLLERDirectorSell5,069.009.3247,243.08136,129.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119050136/0001209191-19-050136-index.htm
2019-09-12FRANK A HOLLERDirectorBuy25,720.003.0077,160.00148,979.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119049550/0001209191-19-049550-index.htm
2020-06-01SHERRINGTON ROBINEVP, Strategy & InnovationBuy8,230.003.5629,298.8018,426.00https://www.sec.gov/Archives/edgar/data/1582313/000120919120033669/0001209191-20-033669-index.htm
2018-12-14GARY PATOUDirectorBuy2,057.003.076,314.9919,459.00https://www.sec.gov/Archives/edgar/data/1582313/000117184318008471/0001171843-18-008471-index.htm
2018-06-14GARY PATOUDirectorBuy8,230.003.7030,451.0020,258.00https://www.sec.gov/Archives/edgar/data/1582313/000117184318004695/0001171843-18-004695-index.htm
2019-12-04GARY PATOUDirectorBuy2,057.003.567,322.9221,516.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119059515/0001209191-19-059515-index.htm
2020-10-28GARY PATOUDirectorBuy2,057.003.767,734.3223,573.00https://www.sec.gov/Archives/edgar/data/1582313/000120919120056222/0001209191-20-056222-index.htm
2020-06-01SIMON N. PIMSTONECEOSell3,000.0014.4343,290.00255,186.00https://www.sec.gov/Archives/edgar/data/1582313/000120919120033578/0001209191-20-033578-index.htm
2019-09-20SIMON N. PIMSTONECEOSell10,395.009.5198,856.45258,122.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119050588/0001209191-19-050588-index.htm
2020-05-29SIMON N. PIMSTONECEOSell5,000.0013.9969,950.00258,186.00https://www.sec.gov/Archives/edgar/data/1582313/000120919120033578/0001209191-20-033578-index.htm
2019-09-17SIMON N. PIMSTONECEOBuy9,259.003.0728,425.13262,633.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119050148/0001209191-19-050148-index.htm
2019-09-17SIMON N. PIMSTONECEOBuy36,008.003.70133,229.60264,143.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119050148/0001209191-19-050148-index.htm
2020-05-26SIMON N. PIMSTONECEOBuy6,172.003.5621,972.32264,294.00https://www.sec.gov/Archives/edgar/data/1582313/000120919120032628/0001209191-20-032628-index.htm
2019-09-17SIMON N. PIMSTONECEOBuy12,345.003.3841,726.10272,209.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119050148/0001209191-19-050148-index.htm
2019-03-19Michael R HaydenDirectorBuy20,576.003.3869,546.8850,924.00https://www.sec.gov/Archives/edgar/data/1582313/000089924319008569/0000899243-19-008569-index.htm
2018-06-21MOHAMMAD AZABDirectorBuy10,288.003.7038,065.6054,498.00https://www.sec.gov/Archives/edgar/data/1582313/000117184318004795/0001171843-18-004795-index.htm
2019-09-13MOHAMMAD AZABDirectorSell23.009.31214.1857,561.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119049864/0001209191-19-049864-index.htm
2018-12-06MOHAMMAD AZABDirectorBuy3,086.003.079,474.0257,584.00https://www.sec.gov/Archives/edgar/data/1582313/000089924318030608/0000899243-18-030608-index.htm
2018-06-21MICHAEL M TARNOWDirectorBuy5,144.003.7019,032.8060,311.00https://www.sec.gov/Archives/edgar/data/1582313/000117184318004796/0001171843-18-004796-index.htm
2019-12-16MOHAMMAD AZABDirectorBuy3,086.003.5610,986.1660,647.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119060910/0001209191-19-060910-index.htm
2018-06-21MICHAEL M TARNOWDirectorBuy2,057.003.667,528.6262,368.00https://www.sec.gov/Archives/edgar/data/1582313/000117184318004796/0001171843-18-004796-index.htm
2019-05-21MICHAEL M TARNOWDirectorBuy2,057.003.216,602.9764,569.00https://www.sec.gov/Archives/edgar/data/1582313/000089924319014470/0000899243-19-014470-index.htm
2019-11-21MICHAEL M TARNOWDirectorBuy2,057.003.517,220.0766,626.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119057754/0001209191-19-057754-index.htm
2018-06-21MICHAEL M TARNOWDirectorBuy5,144.003.0715,792.0867,512.00https://www.sec.gov/Archives/edgar/data/1582313/000117184318004796/0001171843-18-004796-index.htm
2019-11-21MICHAEL M TARNOWDirectorBuy5,144.003.5618,312.6469,713.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119057754/0001209191-19-057754-index.htm
2020-06-09MICHAEL M TARNOWDirectorBuy5,144.003.5218,106.8869,713.00https://www.sec.gov/Archives/edgar/data/1582313/000120919120035608/0001209191-20-035608-index.htm
2020-10-28MICHAEL M TARNOWDirectorBuy5,144.003.7619,341.4474,857.00https://www.sec.gov/Archives/edgar/data/1582313/000120919120056229/0001209191-20-056229-index.htm
2020-10-28MICHAEL M TARNOWDirectorBuy5,144.003.7619,341.4480,001.00https://www.sec.gov/Archives/edgar/data/1582313/000120919120056229/0001209191-20-056229-index.htm
2018-12-11CHARLES J. COHENVP, BiologyBuy4,115.003.0712,633.058,194.00https://www.sec.gov/Archives/edgar/data/1582313/000117184318008430/0001171843-18-008430-index.htm